SCHEMBL15025632

SCHEMBL15025632

Cc1ccnc(C2=CCN(C(=O)O)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.49
CCR5 P51681 1/20 0.49
CCR8 P51685 1/20 0.49
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
GRM5 P41594 4/20 0.43
QDPR P09417 1/20 0.41
WNT3A P56704 2/20 0.40
ABL1 P00519 3/20 0.40
BCR P11274 3/20 0.40
GRM1 Q13255 3/20 0.39
NAMPT P43490 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPC1 O15118 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
KCNH2 Q12809 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3326632 0.83 TRPV1 (0.43) ALDH1A1SMN1; SMN2ABL1BCR
SCHEMBL15024195 0.82 GRM1 (0.60) GRM5WNT3AGRM1NAMPT
SCHEMBL30097493 0.81 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2GRM5GRM1NAMPT
SCHEMBL12100560 0.81 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2GRM5GRM1NAMPT
SCHEMBL28691435 0.78 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2GRM5GRM1NAMPT
SCHEMBL18865732 0.77 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2GRM5QDPRGRM1
SCHEMBL28661925 0.76 NAMPT (0.40) ALDH1A1SMN1; SMN2GRM5QDPRGRM1
SCHEMBL20140095 0.76 HTR1A (0.54) CCR1CCR8ALDH1A1SMN1; SMN2GRM5
SCHEMBL22324995 0.76 QDPR (0.50) ALDH1A1SMN1; SMN2QDPRMEN1KMT2A
SCHEMBL16113804 0.75 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2QDPRNAMPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013083741-A1 1,2,4 -TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 WO disclosed